Rho and Anthera Pharmaceuticals’ Collaborative Partnership in Cystic Fibrosis
Over a three year period, Rho and Anthera Pharmaceuticals developed a collaborative partnership developing a product to treat Cystic Fibrosis. Some highlights of the partnership included:
- Expanding the scope of services being provided
- Gaining efficiencies over the course of multiple studies
- Sharing a commitment to the CF community
Download the case study to read more about this partnership.